NCT00890318 - A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis C | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

July 31, 2009

Conditions

HCV Infection

Interventions

DRUG

ABT-072

Powder contents from capsules mixed in an alternative vehicle, for additional information refer to Arm Description.

OTHER

ketoconazole

Tablet, see Arm Description for intervention information.

DRUG

Placebo

Capsule or powder drug substance from the capsule mixed in an alternative vehicle, for additional information refer to Arm Description.

Trial Locations (1)

Abbott Clinical Pharmaceutical Research Unit, Waukegan